XTX Topco’s AEON Biopharma AEON Stock Holding History

XTX Topco’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,424	Closed	-$20.1K	–	4102
2026 Q1	$20.1K	Sell	20,424 -36,428	-64%	-$40.7K	﹤0.01%	3550
2025 Q4	$62.5K	Buy	56,852 +40,690	+252%	+$38K	﹤0.01%	2780
2025 Q3	$13.1K	Buy	+16,162	New	+$12.5K	﹤0.01%	2405

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco's AEON Position: Q2 2026 in Review

XTX Topco sold out of AEON Biopharma (AEON) in Q2 2026, closing a stake of 20,424 shares — an estimated $20.1K sold.

XTX Topco first reported a position in AEON in Q3 2025 and held it in 3 quarters. The position peaked at $62.5K in Q4 2025. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

XTX Topco reported no remaining AEON Biopharma position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 20,424 AEON Biopharma shares in Q2 2026, an estimated $20.1K.
XTX Topco first reported a position in AEON Biopharma in Q3 2025 and held it in 3 quarters.
XTX Topco's AEON Biopharma position peaked at $62.5K in Q4 2025.
22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.